AI assistant
Sending…
Vera Therapeutics, Inc. — Director's Dealing 2021
May 14, 2021
31944_dirs_2021-05-13_6089a878-ffaf-408a-a050-639c1dd2ae8a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Vera Therapeutics, Inc. (VERA)
CIK: 0001831828
Period of Report: 2021-05-13
Reporting Person: Wolter Jonathan (Chief Financial Officer)
More from Vera Therapeutics, Inc.
Regulatory Filings
2026
Jun 2
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 25